Where is Protect Biotech Incorporation located?

Protect Biotech Incorporation is headquartered in United States.

Where does Protect Biotech Incorporation rank among its competitors?

Protect Biotech Incorporation ranks 6th amongst 10 active competitors, of which 3 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was LEAH Labs, which secured $500K in Aug, 2025.

Who are the top competitors of Protect Biotech Incorporation?

Protect Biotech Incorporation's top competitors include Torigen, LEAH Labs and AlsterScience. Among them, LEAH Labs secured the most recent funding round in August, 2025.

Protect Biotech Incorporation - 2026 Company Profile & Competitors

Protect Biotech Incorporation is an unfunded company based in United States. It operates as a Developer of of companion animal immunotherapy drugs. Protect Biotech Incorporation has not raised any funding yet. The company has 10 active competitors, including 3 funded and 1 that has exited. Its top competitors include companies like Torigen, LEAH Labs and AlsterScience.

Company Details

Developer of of companion animal immunotherapy drugs. It offers a broad-spectrum animal cancer treatment product PT001 for pet animals.

Key Metrics

Location

United States

Stage

Unfunded

Ranked

6^th among 10 active competitors

Similar Companies

Torigen & 11 more

View Protect Biotech Incorporation's full profile

Protect Biotech Incorporation has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Protect Biotech Incorporation include Torigen, LEAH Labs and AlsterScience. Here is the list of Top 10 competitors of Protect Biotech Incorporation, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Torigen 2012, Farmington (United States), Series A	Provider of personalized cancer immunotherapies to the veterinary market	$20.8M	Connecticut Innovations, SoGal Ventures & 15 others	43/100
2nd	LEAH Labs 2018, Scottsdale (United States), Seed	Developer of gene editing tools for dogs to fight against cancer	$1.27M	Ag Startup Engine, 321 Ridgeland Ventures ... & 2 others	37/100
3rd	AlsterScience 2010, Hamburg (Germany), Seed	Provider of immunotherapies for animals	-	HTGF, IFB Innovationsstarter & 2 others	26/100
4th	Jenga Biosciences 2024, Carmel (United States), Unfunded	Developer of cancer treatments for veterinary use	-	-	25/100
5th	Hastim 2003, Toulouse (France), Unfunded	Developer of immunotherapeutic treatments for humans and animals	-	-	24/100
6th	Protect Biotech Incorporation United States, Unfunded	Developer of of companion animal immunotherapy drugs	-	-	24/100
7th	Alv 2020, Oslo (Norway), Unfunded	Developer of immunotherapies for cancer treatment in dogs and cats	-	-	19/100
8th	Zander Therapeutics 2015, La Mesa (United States), Deadpooled	Developer of therapy for cancer and autoimmune diseases in animals	-	-	18/100
9th	Vet Therapeutics 2009, Del Mar (United States), Acquired	Developer of antibody-based therapies to treat cancer in companion animals	-	HHS	18/100
10th	Entest BioMedical 2008, La Mesa (United States), Deadpooled	Developer of immunotherapeutics for canines with cancer and autoimmune disorders	-	-	18/100